Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 5,343,033 | 3,810,241 | 2,458,779 | 1,415,921 | 1,176,283 |
| Cost of Goods | 668,540 | 594,089 | 379,920 | 286,475 | 164,906 |
| Gross Profit | 4,674,493 | 3,216,152 | 2,078,859 | 1,129,446 | 1,011,377 |
| Operating Expenses | 4,227,897 | 3,784,440 | 3,287,515 | 2,919,586 | 2,451,018 |
| Operating Income | 447,136 | -568,199 | -1,207,736 | -1,789,665 | -1,438,735 |
| Interest Expense | 58,234 | 21,805 | 0 | 0 | 0 |
| Other Income | 27,952 | 57,003 | 381,900 | -171,372 | 147 |
| Pre-tax Income | 416,854 | -533,001 | -825,836 | -1,961,037 | -1,438,588 |
| Income Tax | 129,921 | 111,785 | 55,872 | 42,778 | 19,228 |
| Net Income Continuous | 286,933 | -644,786 | -881,708 | -2,003,815 | -1,457,816 |
| Net Income | $286,933 | $-644,786 | $-881,708 | $-2,003,815 | $-1,457,816 |
| EPS Basic Total Ops | 2.63 | -6.12 | -8.45 | -19.43 | -15.71 |
| EPS Basic Continuous Ops | 2.63 | -6.12 | -8.45 | -19.43 | -15.71 |
| EPS Diluted Total Ops | 2.53 | -6.12 | -8.45 | -19.43 | -15.71 |
| EPS Diluted Continuous Ops | 2.53 | -6.12 | -8.45 | -19.43 | -15.71 |
| EPS Diluted Before Non-Recurring Items | 2.53 | -6.12 | -8.45 | -19.43 | -15.23 |
| EBITDA(a) | $588,822 | $-396,437 | $-1,120,061 | $-1,723,387 | $-1,392,278 |